Canada Nootropics Market Size & Outlook, 2021-2030

The nootropics market in Canada is expected to reach a projected revenue of US$ 296.0 million by 2030. A compound annual growth rate of 13.2% is expected of Canada nootropics market from 2022 to 2030.
Revenue, 2021 (US$M)
$97.1
Forecast, 2030 (US$M)
$296.0
CAGR, 2022 - 2030
13.2%
Report Coverage
Canada

Canada nootropics market highlights

  • The Canada nootropics market generated a revenue of USD 97.1 million in 2021 and is expected to reach USD 296.0 million by 2030.
  • The Canada market is expected to grow at a CAGR of 13.2% from 2022 to 2030.
  • In terms of segment, capsules/tablets was the largest revenue generating form in 2021.
  • Drinks is the most lucrative form segment registering the fastest growth during the forecast period.


Nootropics market data book summary

Market revenue in 2021USD 97.1 million
Market revenue in 2030USD 296.0 million
Growth rate13.2% (CAGR from 2021 to 2030)
Largest segmentCapsules/tablets
Fastest growing segmentDrinks
Historical data2018 - 2020
Base year2021
Forecast period2022 - 2030
Quantitative unitsRevenue in USD million
Market segmentationCapsules/Tablets, Powder, Drinks
Key market players worldwideReckitt Benckiser Group PLC, Mental Mojo, Noocube, Mind Lab, truBrain, Nooflux, Zhou Nutrition, Kimera Koffee


Other key industry trends

  • In terms of revenue, Canada accounted for 2.9% of the global nootropics market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. nootropics market is projected to lead the regional market in terms of revenue in 2030.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 3,698.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Nootropics Market Companies

Name Profile # Employees HQ Website

Canada nootropics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to nootropics market will help companies and investors design strategic landscapes.


Capsules/tablets was the largest segment with a revenue share of 51.91% in 2021. Horizon Databook has segmented the Canada nootropics market based on capsules/tablets, powder, drinks covering the revenue growth of each sub-segment from 2018 to 2030.


Hectic lifestyles, brain health-related ailments, and wellness awareness are boosting the market for nootropics in Canada. Nootropics in Canada is expanding significantly, allowing consumers to access a wide variety of products from both domestic and international suppliers. 

Online platforms also provide a convenient way for consumers to research different products, compare reviews, and make informed purchasing decisions. Nootropics can also be used to diagnose and treat different types of sleep disorders, including insomnia, narcolepsy, and sleep apnea. 

These sleeping disorders negatively impact human health and can lead to severe medical conditions such as high blood pressure, stroke, arthritis, and diabetes. Many companies are launching nootropic products to cater to the market for sleep and wellness.

Reasons to subscribe to Canada nootropics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada nootropics market databook

  • Our clientele includes a mix of nootropics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada nootropics market , including forecasts for subscribers. This country databook contains high-level insights into Canada nootropics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada nootropics market size, by form, 2018-2030 (US$M)

Canada Nootropics Market Outlook Share, 2021 & 2030 (US$M)

Canada nootropics market size, by form, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more